Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$246,965
+$10,170 QoQ
Shares Held
682
+1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,696
of 3,139 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Encompass More Asset Management holds $2,871,318 across 7 Drug Manufacturers - General names. AMGN ranks #6 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
14,408 | $830,188 | |
| 2 | JNJ |
Johnson & Johnson
|
2,525 | $641,274 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,935 | $370,807 | |
| 4 | ABBV |
AbbVie Inc.
|
1,118 | $281,333 | |
| 5 | AZN |
Astrazeneca PLC
|
1,482 | $281,016 | |
| 6 | AMGN |
Amgen Inc
This page
|
682 | $246,965 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,710 | $219,735 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,965 | 682 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $236,795 | 673 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $220,279 | 673 | Shares | Sole | 2026-02-03 | |
| 2025-06-30 | $233,977 | 838 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $298,464 | 958 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $369,587 | 1,418 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $432,405 | 1,342 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $368,691 | 1,180 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $410,842 | 1,445 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $264,690 | 919 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||